Global Lomitapide Pregnancy Exposure Registry

Trial Profile

Global Lomitapide Pregnancy Exposure Registry

Phase of Trial: Phase IV

Latest Information Update: 19 Dec 2017

At a glance

  • Drugs Lomitapide (Primary)
  • Indications Hyperlipoproteinaemia type IIa
  • Focus Adverse reactions
  • Sponsors Aegerion Pharmaceuticals
  • Most Recent Events

    • 13 Jan 2016 Status changed from not yet recruiting to recruiting as reported by
    • 27 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top